J&J Talc Settlement
Johnson & Johnson reaches $5.5 billion settlement to resolve most US talc lawsuits.
Anonymous
Key Points
1
A 2016 verdict awarded $72 million to the family of a woman who died of ovarian cancer tied to talc, but the case was overturned a year later, illustrating early high-profile litigation that was later reversed on appeal.
2
The UK talc litigation is described as the largest product liability case in UK history, involving more than 7,000 potential claimants and proceeding in the UK High Court.
3
Previous efforts to resolve talc claims through a shell-company bankruptcy failed, and the litigation resumed in March 2025 after more than three years on hold.
4
Erik Haas, J&J's head of litigation, said the settlement lets the company 'put this matter behind it'.
Johnson & Johnson has agreed to pay $5.5 billion to settle about 69,000 US lawsuits claiming its talc-based baby powder caused ovarian cancer, according to Economic Times. The deal covers 99.75% of remaining claims in federal and state courts, effectively ending a decade-long legal battle over one of the company's most iconic products.
J&J denies that talc causes cancer. The company stopped selling talc-based baby powder in the US in 2020 and worldwide in 2023. Erik Haas, J&J's head of litigation, said the settlement lets the company "put this matter behind it," according to AOL.
How a Decade of Talc Lawsuits Finally Ended
The litigation stretches back years, with early verdicts going both ways. In 2016, a jury awarded $72 million to the family of a woman who died of ovarian cancer linked to talc. That verdict was later overturned on appeal. Still, thousands more cases kept piling up, according to Yahoo Finance.
J&J tried twice to escape the lawsuits through a legal maneuver called a "shell company bankruptcy." The idea was to spin off talc liabilities into a separate company and use bankruptcy to cap payouts. Both attempts failed. The litigation resumed in March 2025 after sitting on hold for more than three years, according to Head Topics.
What the $5.5 Billion Deal Actually Covers
The settlement resolves about 69,000 claims — roughly 99.75% of active US cases. Plaintiffs' lawyers called it a good resolution. J&J stressed that agreeing to pay does not mean admitting guilt. The company says the science does not support a link between talc and cancer, according to Economic Times.
The deal covers claims in both federal and state courts across the US. It does not cover future talc lawsuits filed in the US, and it does not touch cases outside the country, according to AOL.
UK Talc Case Remains Open — and It's Historic
The settlement leaves out the United Kingdom entirely. A separate case is moving through the UK High Court, and it is described as the largest product liability case in UK history, according to Yahoo Finance. More than 7,000 people are potential claimants in that case.
UK claimants argue that J&J knew talc could cause cancer but kept selling it anyway. J&J denies that claim. The UK case is still ongoing, meaning J&J's talc legal troubles are not fully over despite the massive US settlement, according to Head Topics.
J&J Moves to Refocus After Years of Legal Distraction
Talc litigation has hung over J&J for years, diverting attention and resources. By settling 99.75% of US claims at once, the company gets a clear path forward. Haas said the deal lets J&J move on and focus on its core businesses, which include pharmaceuticals and medical devices, according to Whalesbook.
The $5.5 billion figure is large but manageable for a company of J&J's size. The bigger win for the company may be certainty — knowing the bulk of US talc claims are resolved and will not drag on for another decade, according to Economic Times.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
20
Articles
201
Reach
221
A
AnonymousAuthor
